March 14, 2016

A Case of Pranlukast-Induced Anaphylactic Shock


Case Report  Open Access


         

Allergy Asthma Immunol Res. 2016 May;8(3):276-278. English.
Sujeong Kim and Jong-Myung Lee

Abstract
Leukotriene receptor antagonists, which are generally considered safe with a few 
adverse drug reactions, are increasingly used in the treatment of various allergic 
diseases, including asthma and allergic rhinitis. Although a few anaphylactic 
reactions to montelukast have been reported worldwide, there is still a lack of 
reports about severe adverse drug reactions associated with pranlukast. Here, we 
report a case of severe hypersensitivity reaction associated with pranlukast.
 
A 65-year-old woman developed anaphylactic shock that presented as generalized 
urticaria, angioedema, collapse, and loss of consciousness after receiving 
pranlukast. A positive response to oral challenge and skin prick testing with 
pranlukast was observed in the patient. In this case, it was demonstrated that 
pranlukast can induce anaphylaxis, possibly mediated by the IgE-dependent 
pathway.




         

No comments:

Post a Comment